Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0118 USD | -1.67% | -20.27% | -81.56% |
Financials (USD)
Sales 2022 | 16.84 | Sales 2023 | 18.22 | Capitalization | 1.28M |
---|---|---|---|---|---|
Net income 2022 | -76M | Net income 2023 | 53M | EV / Sales 2022 | 4,528,434 x |
Net Debt 2022 | 68.36M | Net Debt 2023 | 43.37M | EV / Sales 2023 | 2,451,077 x |
P/E ratio 2022 |
-0.05
x | P/E ratio 2023 |
1.2
x | Employees | 38 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 100% |
Latest transcript on Evofem Biosciences, Inc.
1 day | -7.69% | ||
1 week | -28.57% | ||
Current month | -14.29% | ||
1 month | -42.86% | ||
3 months | -53.12% | ||
6 months | -83.45% | ||
Current year | -81.25% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 12-12-31 | |
Ivy Zhang
DFI | Director of Finance/CFO | 46 | 18-02-28 |
Amy Raskopf
IRC | Investor Relations Contact | - | 18-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 12-12-31 | |
Kim Kamdar
BRD | Director/Board Member | 56 | 17-12-31 |
Colin Rutherford
BRD | Director/Board Member | 65 | 17-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-06 | 0.0118 | -1.67% | 918 681 |
24-05-03 | 0.012 | -7.69% | 2,495,055 |
24-05-02 | 0.013 | -6.47% | 1,499,167 |
24-05-01 | 0.0139 | -0.71% | 607,348 |
24-04-30 | 0.014 | -5.41% | 561,891 |
Delayed Quote OTC Markets, May 03, 2024 at 03:59 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-81.25% | 733K | |
+26.08% | 662B | |
+22.56% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 289B | |
+13.68% | 234B | |
+4.18% | 198B | |
-10.84% | 194B | |
+8.08% | 167B |
- Stock Market
- Equities
- EVFM Stock